Company Search:
Advanced Search
Sponsored Links
bluebird bio Inc Company Snapshot
bluebird bio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares bluebird bio Inc with three other companies in this sector in the United States: India Globalization Capital, Inc. (2016 sales of $6.37 million of which 98% was Trading), Clinuvel Pharmaceuticals Limited ($5.11 million of which 100% was Biotechnology), and Crispr Therapeutics AG ($5.16 million ).

Sales Analysis. bluebird bio Inc reported sales of $6.16 million for the year ending December of 2016. This represents a sharp decrease of 56.3% versus 2015, when the company's sales were $14.08 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
bluebird bio Inc
  Stock Performance Chart for bluebird bio Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 175.95
(Figures in U.S. Dollars)
1 Week 3.1%   13 Weeks -2.0%  
4 Weeks 23.4%   52 Weeks 169.0%  
bluebird bio Inc Key Data:
  Ticker: BLUE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 6,155,000
(Year Ending Jan 2017).
Employees: 328
  Currency: U.S. Dollars Market Cap: 8,063,954,245
  Fiscal Yr Ends: December Shares Outstanding: 45,830,942
  Share Type: Common Closely Held Shares: 269,783
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.